Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Immediate Therapeutic Effects of 3% Diquafosol and 2% Rebamipide in Dry Eye Disease

NCT07297316 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT07297316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07297316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Immediate Therapeutic Effects of 3% Diquafosol and 2% Rebamipide in Dry Eye Disease
Lead sponsor
Korea University Anam Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 3, 2022
Completion date
August 30, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)